Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. Ginsenoside Rk3, an important and rare saponin in heat-treated ginseng, is generated from Rg1 and has a smaller molecular weight. However, the anti-HCC efficacy and mechanisms of ginsenoside Rk3 have not yet been ch...
Main Authors: | Linlin Qu, Yannan Liu, Jianjun Deng, Xiaoxuan Ma, Daidi Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Journal of Pharmaceutical Analysis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177923000436 |
Similar Items
-
Anti-Photoaging and Anti-Inflammatory Effects of Ginsenoside Rk3 During Exposure to UV Irradiation
by: Shichao Wan, et al.
Published: (2021-10-01) -
Protective effect of ginsenosides Rk3 and Rh4 on cisplatin-induced acute kidney injury in vitro and in vivo
by: Seung-Hoon Baek, et al.
Published: (2017-07-01) -
20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway
by: Ting Xia, et al.
Published: (2020-09-01) -
ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway
by: Huang K, et al.
Published: (2022-12-01) -
Ginsenoside Rk1 bioactivity: a systematic review
by: Abdelrahman Elshafay, et al.
Published: (2017-11-01)